WO1994007140A1 - Procede de separation - Google Patents

Procede de separation Download PDF

Info

Publication number
WO1994007140A1
WO1994007140A1 PCT/GB1993/001972 GB9301972W WO9407140A1 WO 1994007140 A1 WO1994007140 A1 WO 1994007140A1 GB 9301972 W GB9301972 W GB 9301972W WO 9407140 A1 WO9407140 A1 WO 9407140A1
Authority
WO
WIPO (PCT)
Prior art keywords
species
auxiliary species
additional auxiliary
reaction partner
ligand
Prior art date
Application number
PCT/GB1993/001972
Other languages
English (en)
Inventor
Ramadan A. Abuknesha
Original Assignee
Gec-Marconi Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9219743A external-priority patent/GB2270976A/en
Priority claimed from GB929220722A external-priority patent/GB9220722D0/en
Priority claimed from GB9221578A external-priority patent/GB2260609B/en
Priority claimed from GB9224897A external-priority patent/GB2261948A/en
Priority claimed from GB9315995A external-priority patent/GB2269896B/en
Priority claimed from GB9315991A external-priority patent/GB2270158B/en
Application filed by Gec-Marconi Limited filed Critical Gec-Marconi Limited
Priority to EP93920969A priority Critical patent/EP0660933A1/fr
Publication of WO1994007140A1 publication Critical patent/WO1994007140A1/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label

Definitions

  • the present invention relates to a separation method which finds application in immunological detection (e.g. in immunoassay and immunosensors) , to a method suitable for use in detection, to a sensor, and to a test-kit.
  • immunological detection e.g. in immunoassay and immunosensors
  • a method suitable for use in detection to a sensor, and to a test-kit.
  • a separation method suitable for use in an immunological method for the detection of an entity, which separation method includes effecting attachment of an auxiliary species to a support material by use of an additional auxiliary species and a reaction partner for the additional auxiliary species.
  • a method, suitable for use in immunological detection of an entity which method includes effecting attachment of an auxiliary species to a support material by use of an additional auxiliary species and a reaction partner for the additional auxiliary species.
  • a sensor suitable for use in the detection of an entity, which sensor includes an additional auxiliary species provided on a support material, said additional auxiliary species being capable of interacting with a reaction partner for the additional auxiliary species thereby to effect attachment of an auxiliary species to a support material.
  • test-kit which test-kit includes an additional auxiliary species provided on a support material, said additional auxiliary species being capable of interacting with a reaction partner for the additional auxiliary species thereby to effect attachment of an auxiliary species to a support material.
  • An auxiliary species is one which is not itself capable of taking part in a primary immune binding reaction with an entity to be detected or with an authentic entity to be detected.
  • an additional auxiliary species and a reaction partner for the additional auxiliary species may be species which are not themselves capable of taking part in a primary immune binding reaction with an entity to be detected or with an authentic entity to be detected.
  • the additional auxiliary species and the auxiliary species are different species.
  • an additional auxiliary species and a reaction partner for the additional auxiliary species may be used, together with an auxiliary species and a reaction partner for the auxiliary species (i.e. an auxiliary species reaction partner) to bring about indirect attachment of a primary species to a support material.
  • the present invention thus for example may be used to effect a separation (e.g. in an im unoassay method) .
  • a separation in accordance with the present invention may be effected by arranging for a primary species to be associated (in any suitable manner and at any suitable time) with an auxiliary species, arranging for the auxiliary species to be associated with an additional auxiliary species (in any suitable manner and at any suitable time) and arranging for the additional auxiliary species to be associated with a support material (in any suitable manner and at any suitable time) such that the primary species may become indirectly associated with the support material.
  • An additional auxiliary species may be provided on a support material at any suitable time and in any suitable manner as is further disclosed hereinafter.
  • a primary species in accordance with the present invention is a species capable of taking part in a primary immune binding reaction.
  • a primary immune binding reaction in accordance with the present invention is one in which an entity to be detected undergoes a specific binding reaction, or an authentic entity to be detected (as hereinafter defined) undergoes a specific binding reaction, or an entity to be detected and an authentic entity to be detected undergo specific binding reactions. (It will be appreciated that the entity to be detected and the authentic entity to be detected undergo specific binding reactions with other species and not with each other.)
  • an "authentic entity” is an entity which is capable of reacting in a substantially similar manner as an entity to be detected under similar conditions.
  • an authentic entity may, for example, have a chemically defined structure and/or a biologically defined activity.
  • an authentic entity to be detected may be used, for example, as a "standard” or “calibrator”.
  • the entity to be detected is itself an analyte species (as hereinafter disclosed)
  • the authentic entity may be an authentic analyte species (or a suitable derivative thereof) .
  • auxiliary species and an auxiliary species reaction partner may be chosen so as to be capable of interacting with each other by means of specific binding.
  • the auxiliary species is a ligand
  • the auxiliary species reaction partner may be a binder for the auxiliary species; conversely, if the auxiliary species is a binder the auxiliary species reaction partner may be a ligand.
  • an auxiliary species reaction partner may be a species which is not itself capable of taking part in a primary immune binding reaction with an entity to be detected, or an authentic entity to be detected.
  • an auxiliary species reaction partner may be a species which has a part which is capable of undergoing a specific binding reaction with an auxiliary species and a part which is capable of undergoing a specific binding reaction with a primary species; the part which is capable of undergoing a specific binding reaction with an auxiliary species may be considered to be an "auxiliary function".
  • An example of an auxiliary species reaction partner which has an "auxiliary function" and a part which is capable of undergoing a specific binding reaction with a primary species is a bifunctional antibody.
  • any species associated with the auxiliary species reaction partner may become associated with the auxiliary species.
  • Any suitable species may be associated with the auxiliary species reaction partner.
  • a primary species may be associated with an auxiliary species reaction partner.
  • a primary species may be associated with an auxiliary species reaction partner in any suitable manner (e.g. by a non-specific link (such as covalent linking or adsorption) or specific binding (e.g. a ligand-binder link) ) ; a primary species may be linked with an auxiliary species reaction partner directly (e.g by a non-specific link or by a specific binding link) or indirectly (e.g. via other species) ; where a primary species is indirectly associated with an auxiliary species reaction partner a link may be used which link may have one, or more, non-specific links or one, or more, specific binding links or any suitable combination of non-specific links and specific binding links.
  • a link may be used which link may have one, or more, non-specific links or one, or more, specific binding links or any suitable combination of non-specific links and specific binding links.
  • auxiliary species reaction partner is a species which has a part capable of undergoing a specific binding reaction with a primary species
  • a primary species may be associated with the auxiliary species reaction partner by direct specific binding therewith.
  • the auxiliary species reaction partner is a species and is not capable of undergoing specific binding with a primary species
  • the auxiliary species reaction partner may be associated with the primary species by a suitable link or links as hereinbefore disclosed.
  • a primary species may be a primary antibody or a ligand (e.g. an antigen) .
  • a primary species may be an antibody to an entity to be detected or an antibody to an authentic entity to be detected; it will be appreciated that, for a given immunoassay, the antibody to the entity to be detected and the antibody to the authentic entity to be detected will be the same antibody.
  • a primary species may be, for example, an entity to be detected or an authentic entity to be detected.
  • a primary species may be associated in any suitable manner with a detectable species as is further disclosed hereinafter.
  • An additional auxiliary species and an auxiliary species may be associated in any suitable manner and at any suitable time.
  • an auxiliary species may be linked directly or indirectly with a reaction partner for the additional auxiliary species.
  • an auxiliary species may be linked with a reaction partner for an additional auxiliary species by means of a non-specific link (e.g. a covalent link or adsorption) or a specific binding link (e.g. ligand-binder link) or by any suitable combination or selection of such links.
  • a non-specific link e.g. a covalent link or adsorption
  • a specific binding link e.g. ligand-binder link
  • An additional auxiliary species and a reaction partner for an additional auxiliary species may be chosen so as to be capable of interacting with each other by means of specific binding.
  • the reaction partner for the additional auxiliary species may be a binder for the additional auxiliary species; conversely, if the additional auxiliary species is a binder the reaction partner for the additional auxiliary species may be a ligand.
  • a reaction partner for the additional auxiliary species may be a species which is a binder or a species which is a ligand, which binder and ligand may be associated with any other species as appropriate in any suitable manner.
  • a reaction partner for an additional auxiliary species may be a species which has a part capable of undergoing a specific binding reaction with an additional auxiliary species and a part which is capable of undergoing a specific binding reaction with an auxiliary species; an example of such a reaction partner for an additional auxiliary species is a bifunctional antibody.
  • the additional auxiliary species is a binder
  • an auxiliary species which may also act as a reaction partner for an additional auxiliary species For example, if an auxiliary species is an antibody (the auxiliary species reaction partner for which may be a corresponding ligand) then the additional auxiliary species may be an antibody to the auxiliary species and the auxiliary species therefor will also constitute a reaction partner for the additional auxiliary species.
  • a binder which is an additional auxiliary species will have a different specificity from that of a binder which acts as an axuiliary species and as a reaction partner for the additional auxiliary species.
  • An additional auxiliary species may be, for example, a ligand, examples of which are antigenic ligands (such as haptens) and non-antigenic ligands.
  • antigenic ligands examples include 2,4 dinitro- phenol, fluorescein, digitoxin, coumarin and cibacron blue.
  • non-antigenic ligands are ligands of specific ligand-binder pairs (e.g. the ligand biotin in the case of the ligand-binder pair biotin-avidin) .
  • ligands which may be attached to a support material (e.g. by covalent linkage or non- covalent attachment (adsorption) ) , which ligands may find use as additional auxiliary species, are soluble materials for example soluble molecules (e.g. polymers) such as polypeptides, proteins, polysaccharides and conducting polymers; haptenic functions may be covalently coupled to such soluble materials (e.g. polymers).
  • a ligand may be provided as a coating of a polymer on a support material.
  • a reaction partner for the additional auxiliary species may be a binder, such binder being a species capable of binding with the ligand; by way of example, the binder may be a binding protein (e.g. an antibody or a binding partner for a ligand) .
  • a binding protein e.g. an antibody or a binding partner for a ligand
  • the binder therefor may be a binder which is an antibody to the ligand.
  • the additional auxiliary species is a ligand and the ligand is 2,4 dinitrophenol, fluorescein, digitoxin, coumarin or cibacron blue
  • the reaction partner for the additional auxiliary species may be a binder which may be, respectively, anti-2,4 dinitrophenol antibody, anti-fluorescein antibody, anti- digitoxin antibody, anti-coumarin antibody or anti- cibacron blue antibody.
  • an additional auxiliary species is a ligand which ligand is a non-antigenic ligand
  • the ligand may be, for example, such that the binder is a binder which is a binding partner that is a non- immunoglobulin (e.g. a naturally-occurring protein) ; the binding partner may be considered to be the binder of the ligand and the binding partner may be considered to be a reaction partner for the additional auxiliary species.
  • An example of such a binding partner is avidin in the specific ligand-binder pair comprising a biotin-avidin complex.
  • the additional auxiliary species may be a binder.
  • the additional auxiliary species may be a binder (e.g. an antibody) for an antigenic ligand or a binder for a non-antigenic ligand such as a binder of a specific ligand-binder pair; an example of a binder for a non-antigenic ligand is avidin.
  • the additional auxiliary species may be, for example, a binder (e.g. an antibody) for another binder (e.g. antibody) .
  • binders for antigenic ligands which binders may be used as additional auxiliary species are anti-2,4 dinitrophenol antibody, anti-fluorescein antibody, anti-digitoxin antibody, anti-coumarin antibody and anti-cibacron blue antibody.
  • the additional auxiliary species is a binder and the binder is anti-2,4 dinitrophenol antibody, anti-fluorescein antibody, anti-digitoxin antibody, anti-coumarin antibody or anti-cibacron blue antibody
  • the reaction partner for the additional auxiliary species may be a ligand which may be, respectively, 2, 4 dinitrophenol, fluorescein, digitoxin, coumarin or cibacron blue.
  • an additional auxiliary species is a binder which is a binder for a non-antigenic ligand
  • the binder may be a binding partner which is a non- immunoglobulin (e.g. a naturally occurring protein) ; the binding partner may be considered to be the binder of the ligand and the ligand may be considered to be a reaction partner for the additional auxiliary ligand.
  • a binding partner is avidin in the specific ligand-binder pair comprising a biotin-avidin complex.
  • An additional auxiliary species in accordance with the present invention, may be provided on a support material in any suitable manner and at any suitable time, and it is to be understood that in this Specification "providing on a support material” and “provided on a support material” embrace, for example, situations where a support carries an additional auxiliary species and situations where the support material itself, or a part of the support material itself, provides an auxiliary species.
  • an additional auxiliary species e.g. a ligand or a binder
  • an additional auxiliary species may be, for example, attached to the support material.
  • an additional auxiliary species in the form of a ligand
  • an additional auxiliary species e.g. a ligand or a binder
  • the additional auxiliary species may be attached either directly or indirectly in any suitable manner.
  • a non-specific linking ⁇ (covalent linkage or adsorption) or a specific binding linking may be utilised.
  • an additional auxiliary species may be attached to a support material via another species (e.g. a carrier protein) or other species.
  • an auxiliary species may be attached to a support material via one additional auxiliary species (and a reaction partner therefor as appropriate) ; alternatively, by way of further example, if desired, a plurality of additional auxiliary species (and corresponding reaction partners) , may be used to form a "bridge" between an auxiliary species and a support material.
  • a "chain" of additional auxiliary species (and corresponding reaction partners) may be formed via which an auxiliary species may be attached indirectly to a support material.
  • an auxiliary species may be associated with a first additional auxiliary species which may be associated with a second additional auxiliary species and so forth to form a "chain” containing as many additional auxiliary species as is appropriate.
  • any suitable link e.g. non-specific link or specific binding link
  • any suitable combination of Jinks e.g. a plurality of non-specific links, or a plurality of specific binding links, or any combination of non ⁇ specific and specific binding links
  • Jinks e.g. a plurality of non-specific links, or a plurality of specific binding links, or any combination of non ⁇ specific and specific binding links
  • a reaction partner for an additional auxiliary species has a part capable of specific binding with the additional auxiliary species and a part capable of specific binding with another species (e.g. a further additional auxiliary species)
  • a reaction partner may, optionally, be used in a "chain” in accordance with the present invention; thus, for example, a bifunctional species such as a bifunctional antibody may be used in a "chain".
  • the support material is, for example, a polymer
  • units of the polymer may act as additional auxiliary species in the form of ligands.
  • surface groups present on a support material such as polystyrene or modified silica, may act as additional auxiliary species in the form of a ligand.
  • the support material may, if desired, provide oligomers or polymers of an additional auxiliary species in the form of ligands.
  • the surface of a support material may be activated thereby to permit attachment of an additional auxiliary species (e.g. a ligand or a binder) ; for example, the surface of a suitable support material may be activated by chemical treatment to provide free amino groups to which an additional auxiliary species (e.g. a ligand or a binder) may be linked.
  • an additional auxiliary species e.g. a ligand or a binder
  • an oligo er or oligomers of an additional auxiliary species, or a polymer or polymers of an additional auxiliary species may be attached directly or indirectly to a support material.
  • an oligomer or oligomers of a ligand, or an oligomer or oligomers of a binder, or a polymer or polymers of a ligand, or a polymer or polymers of a binder may be attached, directly or indirectly, to a support material.
  • oligomers of an additional auxiliary species may be attached to free amino groups on a support material.
  • an additional auxiliary species may be linked (e.g. covalently or otherwise) to a further species (e.g. a carrier protein or a polymer) and the further species may be associated with the support material such that the additional auxiliary species may become indirectly provided on the support material.
  • a further species e.g. a carrier protein or a polymer
  • oligomers or polymers of an additional auxiliary species may be link (e.g. covalently or otherwise) oligomers or polymers of an additional auxiliary species to a further species (e.g. a carrier protein or a polymer) and the further species may be associated with the support material such that oligomers of the additional auxiliary species or polymers of the additional auxiliary species may become indirectly provided on the support material.
  • a further species e.g. a carrier protein or a polymer
  • an additional auxiliary species is attached to a support material
  • attachment of the additional auxiliary species may be effected at any desired time.
  • an additional auxiliary species may be allowed to bind with an appropriate reaction partner therefor, before, or after, the additional auxiliary species is attached to the support material; however, in general, it may be more convenient to attach an additional auxiliary species to a support material before bringing together the additional auxiliary species and a reaction partner therefor.
  • oligomers or polymers of additional auxiliary species may be advantageous in certain circumstances.
  • more additional auxiliary species may be provided than it is possible to provide when using only single "units" of an additional auxiliary species. Accordingly, for example, the provision of more additional auxiliary species offers the possibility of faster reactions since more additional auxiliary species is available to undergo reaction, with available reaction partner therefor.
  • the present invention provides a method which also includes the step of attaching, either directly, or indirectly, an additional auxiliary species (e.g. a ligand or a binder) to a support material.
  • an additional auxiliary species e.g. a ligand or a binder
  • an auxiliary species may be a ligand or a binder selected from those hereinbefore exe plified and an auxiliary species reaction partner may be a binder or a ligand selected from those hereinbefore exemplified.
  • auxiliary species and auxiliary species reaction partners may be provided by oligomers or polymers of ligands and/or binders; oligomers and polymers of ligands and binders are hereinbefore disclosed.
  • ligands and binders as hereinbefore exemplified may be used as is appropriate in any "chain" which may be formed, as hereinbefore disclosed, to attach an auxiliary species to a support material.
  • ligands and binders for use respectively as additional auxiliary species and reaction partners for additional auxiliary species and for auxiliary species and auxiliary species reaction partners may be chosen such that no unacceptable interference occurs between different ligands and different binders.
  • an auxiliary species in accordance with the present invention may be carried by a suitable carrier material, which carrier material may be attached to a support material.
  • Some carrier materials such as dextran, may be suitable hydrophillic materials (e.g. polymers) to which an auxiliary species (e.g. a ligand or a binder) may be linked (either directly or indirectly) .
  • suitable hydrophillic materials e.g. polymers
  • an auxiliary species e.g. a ligand or a binder
  • carrier materials such as dextran
  • some carrier materials do not adsorb satisfactorily to some surfaces, such as polystyrene surfaces (e.g. those found on polystyrene microtitre plates) ; such carrier materials (e.g. dextran) may be, for example, attached to a surface (e.g. a polystyrene surface) by means of an additional auxiliary species and a reaction partner for the additional auxiliary species.
  • reaction partner for the additional auxiliary species may be associated (either directly or indirectly) with a carrier material and the additional auxiliary species may be associated with a support material such that upon binding between the additional auxiliary species and the reaction partner for the additional auxiliary species, carrier material (and any auxiliary ligand linked thereto) may be attached to a support material.
  • materials to be so linked may be each adsorbed onto a carrier material (such as latex particles) .
  • support materials which may find application in accordance with the present invention are solid phase materials such as a reaction vessel wall, insoluble polysaccharides, microparticles (e.g. particulate microcellulose) , polystyrene (e.g. in the form of wells, beads, microtitre plates, discs, sticks or tubes) , cross-linked dextran (e.g. Sephadex) , insoluble polymer structures, glass surfaces, derivatised silica surfaces (e.g. having silyl groups with chemical functions attached) , soluble polymers attached to a suitable surface (e.g. a glass surface) , microparticulate materials with entrapped ferrous oxide (magnetisable particles) , nylon and polyamides.
  • solid phase materials such as a reaction vessel wall, insoluble polysaccharides, microparticles (e.g. particulate microcellulose) , polystyrene (e.g. in the form of wells, beads, microtitre plates, discs, sticks
  • some types of support materials may be inappropriate for use with some entities to be detected.
  • the entity to be detected contains a metal
  • the use of some types of support materials may be inappropriate (e.g. support materials containing entrapped iron oxide may give rise to unacceptable interference) .
  • Entities to be detected may be, for example, any suitable entities capable of undergoing a specific binding reaction.
  • an entity to be detected may itself be an analyte species.
  • an entity to be detected may be an analyte species comprising a ligand (e.g. an antigenic ligand such as a hapten) .
  • entities to be detected may be analyte species comprising antibodies.
  • steroid hormones such as progesterone, 17 ⁇ -hydroxy progesterone or estradiol (e.g. in a sample of blood, serum, saliva, urine or milk)
  • hormones such as tyroid hormone (e.g. thyroxine or triiodothyronine)
  • steroids in extracts e.g. extracts of solids or liquids
  • drugs such as drugs of abuse (e.g. phenobarbital) and therapeutic drugs (e.g. digoxin) (in for example, a sample of blood, serum, saliva or urine)
  • polypeptide hormones e.g.
  • tumour markers such as marker proteins (e.g. in a sample of blood or serum) , protein antigens, blood proteins (e.g. human serum albumin, immunoglobulins (e.g. IgG) , enzyme markers or receptors) , marker proteins in urine resulting from kidney diseases, pesticides such as insecticides, or herbicides (e.g. in water or soil) , toxins (such as those extracted from feeds and food stuffs) , micro-organisms (e.g. viruses and bacteria) , and antibodies to micro-organisms.
  • tumour markers such as marker proteins (e.g. in a sample of blood or serum) , protein antigens, blood proteins (e.g. human serum albumin, immunoglobulins (e.g. IgG) , enzyme markers or receptors) , marker proteins in urine resulting from kidney diseases, pesticides such as insecticides, or herbicides (e.g. in water or soil) , toxins (such as those extracted from feeds and food
  • complexes of metals are complexes of metals.
  • the present invention may find application in, for example, the detection of complexes of metals such as strong metal complexes which may be regarded as toxic (e.g. in biological terms when present in the environment) .
  • An example of a metal complex which may be detected in accordance with the present invention is methyl mercury.
  • an entity to be detected may be an entity which carries or includes analyte species.
  • an entity to be detected may be a species formed by interaction of an analyte species with a suitable agent.
  • analyte species is a metal ion
  • the agent may be a complexing agent capable of interacting with the metal ion to form an entity (e.g. a metal ion complex) for detection.
  • metal ions may be formed into a complex of a metal by use of a complexing agent and the complex thus formed may act as an entity to be detected in accordance with the present invention.
  • metals may be detected in accordance with the present invention.
  • complexing agents are chelating agents.
  • the present invention may find application, for example, in the detection of an entity to be detected, in any suitable sample.
  • samples of water, soil, living species (such as plants (e.g. vegetables) or animals) or air may provide an entity to be detected, for detection in accordance with the present invention.
  • biological samples in which an entity to be detected may be detected in accordance with the present invention are blood, plasma, serum, urine, saliva and milk.
  • An entity to be detected may be, for example, present in water, an aqueous preparation or a fluid extract (e.g. one prepared by solvent extraction) .
  • An entity to be detected may be, for example, a hapten.
  • the present invention may be utilised, for example, in any suitable configuration, examples of which are given immediately hereinafter:
  • an additional auxiliary species is provided on a support material, said additional auxiliary species being a ligand.
  • reaction partner for the additional auxiliary species is linked by covalent linking to an auxiliary species (e.g. a ligand or a binder) .
  • auxiliary species e.g. a ligand or a binder
  • the reaction partner for the additional auxiliary species may be linked to a plurality of auxiliary species (of the same type) .
  • An auxiliary species reaction partner e.g. a binder or a ligand depending upon whether the auxiliary species is a ligand or a binder
  • a primary species e.g. a primary antibody or an authentic entity to be detected
  • Indirect attachment of primary species to the support material may be effected by binding between the auxiliary species and the auxiliary species reaction partner and by binding between the reaction partner for the additional auxiliary species and the additional auxiliary species.
  • Any detectable species associated with the primary species which primary species is indirectly associated with the support material may be detected or determined in any manner suitable to the detectable species used;
  • Indirect attachment of a primary species to the support material and detection or determination of any detectable species may be effected substantially as hereinbefore disclosed in (i) ; (iii) In a further configuration, an additional auxiliary species is provided on a support material, said additional auxiliary species being a ligand.
  • a reaction partner for the additional auxiliary species is a binder for the ligand.
  • auxiliary species e.g. a ligand or a binder
  • auxiliary species e.g. covalently
  • an antibody species which antibody species is capable of undergoing specific binding with the reaction partner for the additional auxiliary species may be regarded as an anti-antibody antibody species. More than one of the antibody species (each having one or a plurality of auxiliary species attached) may become attached to the reaction partner for the additional auxiliary species.
  • Indirect attachment of primary species to the support material may be effected in a manner similar to that hereinbefore disclosed in (i) with the exception that the auxiliary species is indirectly attached to the reaction partner for the additional auxiliary species (by means of binding between the antibody species and the reaction partner for the auxiliary species) .
  • Detection or determination of any detectable species may be effected substantially as hereinbefore disclosed in (i) ;
  • an additional auxiliary species is provided on a support material, said additional species being a binder.
  • a reaction partner for the additional auxiliary species is provided in the form of a plurality of substantially similar ligands linked together.
  • An auxiliary species is (or a plurality of auxiliary species, of the same type, are) linked (e.g. covalently) to a binder for the reaction partner for the additional auxiliary species, which binder may be substantially the same type of species as the additional auxiliary species provided on the support material.
  • Indirect attachment of primary species to the support material may be effected in a manner substantially similar to that hereinbefore disclosed in (i) with the exception that the auxiliary species may be associated with the additional auxiliary species via reaction partner for the additional auxiliary species and the binder therefor.
  • the reaction partner for the additional auxiliary species provides more than two ligands
  • more than one binder therefor associated with one or more auxiliary species
  • Detection or determination of any detectable species may be effected substantially as hereinbefore disclosed in (i) ;
  • a configuration similar to that hereinbefore disclosed in (iv) may be used with the exceptions that (a) the reaction partner for the additional auxiliary species is provided in the form of a ligand (of a first type) , capable of binding with the additional auxiliary species, linked to one ligand of a second type, or a plurality of ligands of a second type, (said second type being different from said first type) and (b) an auxiliary species is, or a plurality of auxiliary species (of the same type) are, linked to a binder for the ligand or ligands of the second type.
  • Indirect attachment of primary species to the support material may be effected in a manner similar to that hereinbefore disclosed in (iv) with the exception that the auxiliary species may be associated with the additional auxiliary species (via the reaction partner for the additional auxiliary species) by means of ligand of the second type and binder for ligand of the second type.
  • reaction partner for the additional auxiliary species provides more than one ligand of the second type
  • more than one binder therefor associated with one or more auxiliary species
  • Detection or determination of any detectable species may be effected substantially as hereinbefore disclosed in (i) ; (vi) In a further configuration an additional auxiliary species, said additional auxiliary species being a ligand, is provided on a support material.
  • a reaction partner for the additional auxiliary species is provided in the form of a bifunctional binding species having two different types of binding function (one capable of binding with the additional auxiliary species and one capable of binding with a ligand of a different type) . .
  • auxiliary species is, or a plurality of auxiliary species (of the same type) are, attached (e.g. covalently) to said ligand of a different type.
  • Indirect attachment of a primary species to the support material may take place in a manner similar to that hereinbefore disclosed in (i) with the exception that the auxiliary species is indirectly attached to the reaction partner for the additional auxiliary species by means of said ligand of a different type.
  • Detection or determination of any detectable species may be effected substantially as hereinbefore disclosed in (i) ;
  • an additional auxiliary species is provided on a support material, such additional auxiliary species being a ligand.
  • reaction partner for the additional auxiliary species is linked by covalent linking to a ligand of a different type from that provided on the support material; if desired the binder may be linked to a plurality of said ligands of a different type.
  • An auxiliary species is, or a plurality of auxiliary species (of the same type) are, linked to binder for the said ligand of a different type.
  • Indirect attachment of a primary species to the support material may take place in a manner similar to that hereinbefore disclosed in (i) with the exception that auxiliary species is indirectly attached to the reaction partner for the additional auxiliary species via said ligand of a different type and binder therefor.
  • Detection or determination of any detectable species may be effected substantially as hereinbefore disclosed in (i) ;
  • an additional auxiliary species is provided in the form of a binder and a reaction partner for the additional auxiliary species is a ligand which may be bound by the binder.
  • the reaction partner for the additional auxiliary species is linked, by covalent linking, to an auxiliary species (which may be a binder or a ligand) .
  • a support material is used upon which there is provided a binder for the additional auxiliary species.
  • the binder for the additional auxiliary species may be an antibody which may be considered to be an anti- antibody antibody.
  • An auxiliary species reaction partner may be arranged to be associated with primary species as hereinbefore disclosed in (i) .
  • Indirect attachment of a primary species may be effected by binding between the auxiliary species reaction partner and the auxiliary species, binding between the reaction partner for the additional auxiliary and the additional auxiliary species and binding between the binder provided on the support material and the additional auxiliary species.
  • any of the binding reactions involved in the indirect attachment of primary species to a support material may be arranged to take place in any appropriate or convenient manner or time and in any appropriate or convenient order.
  • Detection or determination of any detectable species may be effected substantially as hereinbefore disclosed in (J) ; (ix)
  • additional auxiliary species is provided on a support material which additional auxiliary species is a binder for a reaction partner for the additional auxiliary species; in this configuration the reaction partner for the additional auxiliary binder is also a binder.
  • the additional auxiliary species may thus be, for example, an anti-binder antibody.
  • the reaction partner for the additional auxiliary species may, in this configuration, also constitute an auxiliary species in that it may be a binder capable of binding with a ligand, which ligand is an auxiliary species reaction partner.
  • the auxiliary species reaction partner may be arranged to be associated with a primary species in any suitable manner.
  • Indirect attachment of primary species to the support material may be effected by binding between the additional auxiliary species and the binder which constitutes both an auxiliary species and a reaction partner for the additional auxiliary species.
  • an additional auxiliary species is introduced in high concentration to a support material directly (e.g. by covalent linkage) , or indirectly, or a support material itself is arranged to provide an additional auxiliary species;
  • reaction partner for the additional auxiliary species is linked (e.g. covalently) with an auxiliary species
  • an auxiliary species reaction partner is linked (e.g. by covalent linking) to an authentic entity of interest;
  • an anti-entity antibody (which may be termed, for example, a primary antibody) , is labelled with appropriate detectable species capable of giving rise to a signal (e.g.fluorescent substances or enzymes) ;
  • a primary immune reaction an entity to be detected (if present) , suitable amounts of labelled anti-entity antibody, and authentic entity linked to the auxiliary species reaction partner are allowed to mix in solution.
  • the primary immune reaction may be expected to attain or approach equilibrium in a short period of time (e.g. at a temperature of 37°C to 42°C) thereby to produce a primary immune reaction mixture. It will be appreciated that the primary reaction mixture may contain, inter alia , bound and unbound fractions.
  • Auxiliary species linked to reaction partner to the additional auxiliary species is subsequently introduced to the primary immune reaction mixture such that binding may occur between the auxiliary species and the auxiliary species reaction partner.
  • the support material provided with additional auxiliary species is used to effect attachment, indirectly, of primary species to the support material by binding between the additional auxiliary species and the reaction partner for the additional auxiliary species.
  • auxiliary species it is possible to arrange for auxiliary species to be present in very large excess with respect to the corresponding auxiliary species reaction partner, such that the binding reaction between them may be expected to occur rapidly and efficiently with a high proportion of the auxiliary species reaction partner becoming bound with the auxiliary species.
  • some of the labelled primary antibodies may be retained on the support material.
  • the proportions of retained primary antibodies carrying detectable species will depend upon the concentration of "competing" entity, if any, in a given sample; the competing entity may be a standard or an unknown quantity.
  • Washing of the support material with appropriate buffers may be used to remove unbound materials and detectable species activity associated with the support material may be measured by any suitable method such as those known in the art.
  • detectable species activity may be eluted into solution using appropriate buffers to facilitate measurement of such species.
  • a washing step may not be required; thus, detectable species activity associated with the support material (which may be, for example, a sensor surface) may be measured in the presence of unbound material.
  • an anti-entity antibody (which may be termed, for example, a primary antibody) which anti-entity antibody is to act as a "signal" antibody] is conjugated to a detectable species which is capable of giving rise to a signal (e.g. a fluorescent substance or an enzyme) ;
  • hybrid complex which comprises an "immobilising” antibody (which is also an antibody to an entity to be detected) which is conjugated to an auxiliary species reaction partner;
  • an entity to be detected (which may be, for example, antigenic substances of high molecular weight) ;
  • reaction mixture formed in (iii) is brought into contact with support material upon which is provided additional auxiliary species.
  • additional auxiliary species By virtue of binding between the reaction partner for the additional auxiliary species and the additional auxiliary species, only "signal" antibody bound to an entity to be detected becomes attached to the support material.
  • Washing the support material with appropriate buffer may be used to remove unattached "signal" antibody.
  • Detectable species left on the support material may be measured by any suitable method such as those known in the art.
  • detectable species activity may be eluted into solution using appropriate buffers to facilitate measurement of such species.
  • a washing step may not be required; thus, detectable species associated with the support material (which may be, for example, a sensor surface) may be measured in the presence of unbound material.
  • an additional auxiliary species may be associated with a support material and an antibody to a reaction partner for the additional auxiliary species may be used to link the reaction partner for the additional auxiliary species to an auxiliary species, said antibody being an antibody both to the reaction partner to the additional auxiliary species and to the auxiliary species;
  • an additional auxiliary species may be provided on a support material and an antibody to a reaction partner for the additional auxiliary species may be linked (e.g. covalently) to an auxiliary species;
  • an additional auxiliary species in the form of a ligand may be provided on a support material and a reaction partner for the auxiliary species may be a species which has a part capable of undergoing a specific binding reaction with an additional auxiliary species and a part which is capable of undergoing a specific binding reaction with an auxiliary species which auxiliary species is in the form of a ligand (being a different type of ligand from the ligand constituting the additional auxiliary species) ;
  • an additional auxiliary species in the form of a ligand may be provided on a support material, a reaction partner for the additional auxiliary species is provided, an auxiliary species is provided and a bifunctional species is used to link the reaction partner for the additional auxiliary species and the auxiliary species, said bifunctional species having a first part capable of specific binding with the reaction partner for the additional auxiliary species and a second part, which is a different function from the first part, capable of binding with the auxiliary species;
  • an additional auxiliary species in the form of a binder may be provided on a support material.
  • a reaction partner for the additional auxiliary species may then be a ligand and may be covalently linked to an auxiliary species which is a different ligand.
  • An auxiliary species reaction partner may then be a binder for the auxiliary species;
  • an additional auxiliary species in the form of a binder may be provided on a support material, a reaction partner for the additional auxiliary ligand may then be a ligand and may be covalently linked to another, different, binder which then may constitute an auxiliary species.
  • An auxiliary species reaction partner may then be another, different, ligand;
  • an additional auxiliary species in the form of a binder may be provided on a support material.
  • a reaction partner for the additional auxiliary species may be provided in the form of a ligand and this may be linked to an auxiliary species which is a ligand of the same type as the reaction partner for the additional auxiliary species.
  • An auxiliary species reaction partner may then be provided in the form of a binder which may be of substantially the same type as the binder which is the additional auxiliary species.
  • the additional auxiliary species is a binder
  • an additional auxiliary species is provided on a support material. Also there is provided a reaction partner for the additional auxiliary species and a bifunctional species having a part capable of specific binding with the reaction partner for the additional auxiliary species and a part capable of specific binding with a primary species.
  • Indirect attachment of a primary species may be effected by binding between the additional auxiliary species and the reaction partner for the additional auxiliary species and by binding between the bifunctional species and the reaction partner for the additional auxiliary species (which reaction partner for the additional auxiliary species is also serving as an auxiliary species) ; (IX) an additional auxiliary species is provided on a support material.
  • a reaction partner for the additional auxiliary species is also provided.
  • the reaction partner may be capable of also acting as an auxiliary species, in the form of a ligand, with which an auxiliary species reaction partner comprising a binder may undergo specific binding.
  • the practical importance of a separation step is based upon the fact that the efficiency of the step, the simplicity (or otherwise) thereof, and the speed thereof may influence the general properties of an assay method and may influence the performance of an assay method.
  • Separation of bound and unbound fractions of detectable species may be effected using a solid phase immobilised antibody technique in which primary antibody is adsorbed onto a surface of a reaction vessel (e.g. polystyrene tubes) or covalently linked to a micro- particulate material such as microcellulose, Sephadex or micro-particulate material with entrapped ferrous oxide (magnetisable particles) .
  • a reaction vessel e.g. polystyrene tubes
  • a micro- particulate material such as microcellulose, Sephadex or micro-particulate material with entrapped ferrous oxide (magnetisable particles)
  • immobilised primary antibodies in separation in an immunoassay may suffer from several disadvantages; for example interaction between primary antibody and an entity (or an authentic entity) may be considerably slower (e.g. due to diffusion considerations) than that which takes place with the same primary antibody and entity (or authentic entity) in solution (i.e. a longer time may be required to reach equilibrium) . Also, the immobilisation of antibody on a solid phase is not a problem-free procedure; thus, for example, it can be difficult to control or reproduce and also serious protein leakage may occur.
  • the present invention may offer the advantages of reactions in solution with the convenience of a rapid solid-phase separation technique.
  • a primary immune reaction may be allowed to proceed in solution and then separation may be effected.
  • the present invention may also offer for assays and for sensors, for example immunosensors such as optical immunosensors and electrochemical immunosensors, the possibility that a surface carrying an additional auxiliary species in accordance with the present invention may be the same for a variety of, or all, entities to be detected thereby providing a generic assay or sensor construction.
  • immunosensors such as optical immunosensors and electrochemical immunosensors
  • a surface carrying an additional auxiliary species in accordance with the present invention may be the same for a variety of, or all, entities to be detected thereby providing a generic assay or sensor construction.
  • a combination comprising a sensor surface carrying an additional auxiliary species in accordance with the present invention may also, for example, be such as to permit regeneration for multiple reuse; for example, such a combination of a sensor surface carrying additional auxiliary species may be regenerated by removal of bound substances by washing with a suitable buffer preparation (e.g. 0.1M glycine-HCl at pH 2.5).
  • a suitable buffer preparation e.g. 0.1M glycine-HCl at pH 2.5.
  • additional auxiliary species may be selected so as to be stable to multiple treatment with low or high pH organic solvents and/or chaotropic reagents thereby to permit regeneration for multiple reuse.
  • the present invention thus offers the possibility of constructing a non-dedicated sensor such as an immunosensor or immunoelectrode.
  • an electrochemical immunosensor may be provided in which an electrode surface is coated with a conducting polymer (e.g. polypyrrole polymer) which may be arranged to act as an additional auxiliary species (in the form of a ligand) .
  • a conducting polymer e.g. polypyrrole polymer
  • antibodies to the conducting polymer (e.g. polypyrrole polymer) , or segments thereof, may be generated by suitable techniques such as those known in the art; a combination comprising an electrode surface and coatings of a conducting polymer may be, for example, such as to permit regeneration for multiple reuse.
  • a detectable species for use in such an electrochemical immunosensor may be arranged to provide an electroactive species.
  • the present invention may offer the possibility of avoiding such disadvantages in that a sensor in accordance with the present invention may not need to be a dedicated sensor.
  • detection of entities in accordance with the present invention may use an immunosensor technique.
  • an additional auxiliary species may be immobilised on a surface of a sensor device (e.g. on a glass surface, on a quartz surface, or on the surface of an electrode) .
  • signal generation may be detected by a suitable method appropriate to the nature of the signal generated by the detectable species (e.g. a means for measuring fluorescent emission may be used when a detectable species is a fluorescence producing species) .
  • the present invention may make use of an inactive species which may be attached as required to be utilised in accordance with the present invention.
  • an active species may be such as to be reconstitutable to an active form.
  • An inactive form of a species may be prepared by drying and/or freeze-drying (lyophilising) .
  • any species or combination of species suitable for use in accordance with the present invention may be rendered inactive (e.g. by drying and/or freeze-drying (lyophilising)) so as to produce a reconstitutable reagent system or reconstitutable reagent material.
  • Reconstitution may be effected in any suitable manner, for example, by addition of a reconstituting agent such as a suitable solvent (e.g. water) , or a suitable solution (e.g. an aqueous solution) or a suitable sample (e.g. an aqueous sample) .
  • a suitable solvent e.g. water
  • a suitable solution e.g. an aqueous solution
  • a suitable sample e.g. an aqueous sample
  • the present invention may make use of a "switchable" species.
  • a “switchable” species for example, where an additional auxiliary species, or a reaction partner for the additional auxiliary species, or an auxiliary species, or an auxiliary reaction partner is a ligand, the ligand may be provided in a first • 'inactive-' form which may be formed into an • 'active*' form capable of interacting with another species.
  • the present invention may find application in, for example, label-free or detectable species-dependent (e.g. tracer species-dependent) assay methods such as enzyme- immunoassay, fluoro-immunoassay and radio-immunoassay.
  • the present invention may find application in antibody-labelled or antigen-labelled assays.
  • detectable species e.g. tracer species
  • Any suitable detectable species may be used as a label in accordance with the present invention.
  • detectable species are enzymes (e.g. alkaline phosphatase, 3-galactosidase and horse-radish peroxidase) , species capable of giving a fluorescent signal (e.g. fluorophores (or polymeric fluorophores) ) , chemiluminescent compounds, bioluminescent compounds, radioisotopes, dyes, and detectable structures (such as ligand species (or polymers or a ligand species) , and binder species (or polymers of a binder species) ) .
  • fluorophores are fluoresceins, coumarins and rhodamine.
  • Detection or determination of a signal from a detectable species may be effected in any suitable manner such as those known in the immunochemical field.
  • any suitable time indicates at a suitable time during the performance of a method in accordance with present invention.
  • antibody as used in this Specification embraces whole antibody or antibody fragments such as Fab and (Fab) 2 and, accordingly, the.term “antibodies” used herein embraces whole antibodies and antibody fragments.
  • an antibody for use in accordance with the present invention may be prepared by any suitable method, such as those known for raising polyclonal and monoclonal antibodies; thus, antibodies may be raised, for example, by immunising animals.
  • the present invention may find application in any suitable form of immunological detection or immunoassay examples of which are heterogeneous immunoassay methods, competitive immunoassay methods, non-competitive immunoassay methods, sandwich immunoassay methods and direct immunoassay methods.
  • the present invention may find application in multi-entity (e.g. multi-analyte species) detection and in ratiometric detection.
  • multi-entity e.g. multi-analyte species
  • ratiometric detection e.g. multi-analyte species
  • the present invention may find application in qualitative detection of an entity or entities, which may also be considered to be qualitative analysis, or in quantitative detection of an entity or entities, which may also be considered to be quantitative analysis (i.e. measurement or determination of an entity or entities) .
  • the present invention may be utilised with samples which contain an entity to be detected and with samples which contain substantially no entity to be detected (e.g. such as in the case of a "zero" standard sample or an "unknown” sample, which upon subjecting to detection in accordance with the present invention, is found to contain substantially no entities to be detected) .
  • samples which contain substantially no entity to be detected e.g. such as in the case of a "zero" standard sample or an "unknown" sample, which upon subjecting to detection in accordance with the present invention, is found to contain substantially no entities to be detected.
  • the present invention may be used to "probe" for an entity, whether or not a particular entity is present in a particular sample.
  • 5(6)-carboxy fluorescein was selected as an example of an additional auxiliary species and was conjugated to bovine serum albumin (BSA) by reacting 5(6)-carboxy fluorescein-N-hydroxy succinimide ester (6.0 mg in 200 ⁇ l of dimethyl formamide (DMF)) with BSA (50 mg in 10 ml of 50mM NaHC0 3 solution, pH 8.6).
  • BSA bovine serum albumin
  • the resulting conjugate was purified by dialysis and treatment with 1% activated Norit A charcoal.
  • the resulting purified BSA-CF conjugate (being a conjugate of a carrier protein and additional auxiliary species) was attached to the inner walls of polystyrene microtitre plate wells by adsorption.
  • Anti-fluorescein antiserum was raised by injecting sheep with BSA-CF conjugate (see Example 1) , according to known immunological procedures, at monthly intervals for 9 months.
  • Purified antibodies were isolated, from antiserum thus produced, by im unoaffinity chromatography using 5(6)-carboxy-2',7'-diochlorofluorescein coupled to AH- Sepharose (Pharmacia) as an affinity matrix. Bound antibodies were eluted from the affinity matrix by 20% acetonitrile and 1% propionic acid in distilled water.
  • AMCP 7-amino-4-methyl coumarin-3-propionic acid
  • Anti-AMCP antiserum was raised in sheep by injecting key-hole limpet haemocyanin (KLH)-AMCP conjugate, in accordance with known immunological procedures, at monthly intervals for 9 months.
  • KLH key-hole limpet haemocyanin
  • Purified antibodies were isolated, from the antiserum thus produced, by immunoaffinity chromatography using 7-hydroxy-4-methyl coumarin-3-propionic acid coupled to AH Sepharose as affinity matrix. Bound antibodies were eluted from the affinity matrix by a mixture of 20% acetonitrile and 1% propionic acid in distilled water.
  • Atrazine was selected as an entity to be detected (i.e. in this Example the entity is itself an analyte species) to illustrate determination of an entity in accordance with the present invention.
  • an atrazine derivative(*) was selected to act as an authentic entity to be detected (in this case an authentic analyte species) .
  • the atrazine derivative was covalently linked to anti-AMCP IgG (see Example 4) by reacting an N-hydroxy succinimide ester of the atrazine derivative (0.35 mg) with the IgG (20 mg) in a manner similar to the conju ⁇ gating procedure hereinbefore disclosed in Example 3.
  • the resulting conjugate was purified by gel filtration on a Sephadex G50 column.
  • 6- ⁇ 4-chloro-6-[ (methyl ethyl) amino]-1,3 ,5- triazine-2-yl ⁇ thio ⁇ -propionic acid 6- ⁇ 4-chloro-6-[ (methyl ethyl) amino]-1,3 ,5- triazine-2-yl ⁇ thio ⁇ -propionic acid.
  • Anti-atrazine antiserum was raised in rabbits by injecting atrazine derivative(*)-KLH conjugate according to known immunological procedures for 9 months.
  • the antiserum thus produced was used for the development of enzyme immunoassay methods for the measurement of atrazine.
  • 6- ⁇ 4-chloro-6-[ (methyl ethyl) amino]-1,3,5- triazine-2-yl ⁇ amino ⁇ -hexanoic acid 6- ⁇ 4-chloro-6-[ (methyl ethyl) amino]-1,3,5- triazine-2-yl ⁇ amino ⁇ -hexanoic acid.
  • Microtitre plates (coated with additional auxiliary species as disclosed in Example 1) were treated to attach to the inner walls of the wells, auxiliary species thereby to immobilise auxiliary species on the plates.
  • HRP horse radish peroxidase
  • a calibration graph for atrazine was constructed by plotting Optical Density (OD) at 405 nm against atrazine concentrations added to the assay wells.
  • OD Optical Density
  • microtitre plate was treated as described in Example 7 paragraph (e) .
  • a microtitre plate was prepared as in Example 7 paragraph (a) to give a plate having auxiliary species attached thereto via a reaction partner for an additional auxiliary species and an additional auxiliary species.
  • N-hydroxy succinimide ester derivatives of carboxylic acid functions were prepared by reacting 1 mmole of a carboxylic acid function containing compound in dimethyl formamide and 1.1 mmole of N-hydroxy succinimide and 1.1 mmole of dicyclohexyl carbodiimide at 4°C for 72 hours.
  • the esters thus prepared were able to be used for conjugation to proteins without further treatment.
  • the addition of a conjugate may be delayed until a selected point in an immunoassay.

Abstract

La présente invention concerne un procédé de séparation qui a des applications dans la détection immunologique (par exemple dans les dosages immunologiques et dans les détecteurs immunologiques), un procédé utile pour des détections, un détecteur et un kit d'analyse. L'invention fournit entre autres un procédé de séparation utile pour la détection immunologique d'une substance. Dans ce procédé, on effectue la fixation d'une espèce auxiliaire à un matériau de support en utilisant une espèce auxiliaire additionnelle et un partenaire de réaction pour l'espèce auxiliaire additionnelle. L'espèce auxiliaire additionnelle peut être, par exemple, un ligand ou un agent de liaison.
PCT/GB1993/001972 1992-09-18 1993-09-17 Procede de separation WO1994007140A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP93920969A EP0660933A1 (fr) 1992-09-18 1993-09-17 Procede de separation

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
GB9219743.3 1992-09-18
GB9219743A GB2270976A (en) 1992-09-18 1992-09-18 Immunoassay/separation process using an auxiliary species on a support
GB929220722A GB9220722D0 (en) 1992-10-01 1992-10-01 Analysis
GB9220722.4 1992-10-01
GB9221578.9 1992-10-14
GB9221578A GB2260609B (en) 1991-10-18 1992-10-14 Separation and analysis
GB9224897.0 1992-11-27
GB9224897A GB2261948A (en) 1991-11-27 1992-11-27 Analysis
GB9315991.1 1993-08-02
GB9315995.2 1993-08-02
GB9315995A GB2269896B (en) 1992-08-03 1993-08-02 Separation method
GB9315991A GB2270158B (en) 1992-08-03 1993-08-02 Detection

Publications (1)

Publication Number Publication Date
WO1994007140A1 true WO1994007140A1 (fr) 1994-03-31

Family

ID=27547177

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1993/001972 WO1994007140A1 (fr) 1992-09-18 1993-09-17 Procede de separation

Country Status (2)

Country Link
EP (1) EP0660933A1 (fr)
WO (1) WO1994007140A1 (fr)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0077671A1 (fr) * 1981-10-19 1983-04-27 Ortho Diagnostic Systems Inc. Réactifs immunologiques employant des supports polymères
EP0177191A1 (fr) * 1984-09-05 1986-04-09 Serono Diagnostics Partners (A Massachusetts Limited Partnership) Méthodes d'essai
WO1987004794A1 (fr) * 1986-02-06 1987-08-13 Microbiological Associates, Inc. Agglutination de latex a l'aide d'un systeme d'avidine/biotine
WO1992016838A1 (fr) * 1991-03-20 1992-10-01 Gec-Marconi Limited Technique de separation
EP0538053A1 (fr) * 1991-10-18 1993-04-21 Gec-Marconi Limited Séparation et analyse

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0077671A1 (fr) * 1981-10-19 1983-04-27 Ortho Diagnostic Systems Inc. Réactifs immunologiques employant des supports polymères
EP0177191A1 (fr) * 1984-09-05 1986-04-09 Serono Diagnostics Partners (A Massachusetts Limited Partnership) Méthodes d'essai
WO1987004794A1 (fr) * 1986-02-06 1987-08-13 Microbiological Associates, Inc. Agglutination de latex a l'aide d'un systeme d'avidine/biotine
WO1992016838A1 (fr) * 1991-03-20 1992-10-01 Gec-Marconi Limited Technique de separation
EP0538053A1 (fr) * 1991-10-18 1993-04-21 Gec-Marconi Limited Séparation et analyse

Also Published As

Publication number Publication date
EP0660933A1 (fr) 1995-07-05

Similar Documents

Publication Publication Date Title
JP3267613B2 (ja) イオン捕獲結合アッセイにおける非特異的結合遮断薬を含む試薬
US5028535A (en) Threshold ligand-receptor assay
AU609241B2 (en) Ion-capture assays and devices
US5985579A (en) Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays
US5459078A (en) Methods and reagents for performing ion-capture digoxin assays
CA2164939A1 (fr) Detection rapide d'analytes au moyen de recepteurs immobilises sur des particules solubles de l'ordre du sous-micron
EP0640216B1 (fr) Technique de separation
US5459080A (en) Ion-capture assays using a specific binding member conjugated to carboxymethylamylose
JPH10253632A (ja) 分析方法、キット及び装置
JPS5923251A (ja) 多価抗原の測定法及び測定試薬
US5691207A (en) Analyte assay using superaggregated complex as labelled reagent
EP0660935B1 (fr) Detection immunologique au moyen de deux marqueurs detectables
JP3484540B2 (ja) 可溶性サブミクロン粒子上に固定化した抗体による抗原の無作為検出
US6225043B1 (en) Separation and analysis
JP3267614B2 (ja) カルボキシメチルアミロースに結合させた結合メンバーを使用するイオン捕獲アッセイ
EP0653065B1 (fr) Procede de separation
WO1994007140A1 (fr) Procede de separation
GB2271634A (en) Assay comprising an immobilised additional auxiliary species
GB2261948A (en) Analysis
JP4302798B2 (ja) リガンド結合表面の調製方法
GB2270976A (en) Immunoassay/separation process using an auxiliary species on a support
WO1994012878A1 (fr) Procede de separation
GB2270158A (en) Immunoassay using two detectable species
GB2273157A (en) Immunological detection/separation using a plurality of immobilised binding agents

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1993920969

Country of ref document: EP

ENP Entry into the national phase

Ref country code: US

Ref document number: 1995 403733

Date of ref document: 19950427

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 1993920969

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

ENP Entry into the national phase

Ref country code: US

Ref document number: 1997 807317

Date of ref document: 19970227

Kind code of ref document: A

Format of ref document f/p: F

WWW Wipo information: withdrawn in national office

Ref document number: 1993920969

Country of ref document: EP